Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Teva Pharmaceuticals USA, Inc

US Class II Ongoing · initiated 2024-08-08

Superpotent Drug

Preferred Pharmaceuticals, Inc.

US Class II Ongoing · initiated 2024-08-08

Failed Impurities/Degradation Specifications - at 18-month Stability testing

Taro Pharmaceuticals U.S.A., Inc.

US Class III Completed · initiated 2024-08-07

Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the …

JAMP Rabeprazole - 10mg delayed-release Tablet

Canada Type II Ongoing · initiated 2024-08-07

Product quality. Verify if your product is affected.Contact the recalling firm if you have any questions about the recall. Report any health product safety comp…

Dr. Reddy's Laboratories, Inc.

US Class II Ongoing · initiated 2024-08-06

Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.

Dr. Reddy's Laboratories, Inc.

US Class II Ongoing · initiated 2024-08-06

Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.

Dr. Reddy's Laboratories, Inc.

US Class II Ongoing · initiated 2024-08-06

Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.

JAMP Digoxin 0.125 MG, 0.0625MG

Canada Type I Ongoing · initiated 2024-08-06

Product safety. If you are taking this medication, speak with your pharmacist as soon as possible. Your pharmacist will check if your product is affected and pr…

Zeco LLC

US Class II Completed · initiated 2024-08-05

CGMP Deviations: sterile water not used for production

Zeco LLC

US Class II Completed · initiated 2024-08-05

CGMP Deviations: sterile water not used for production

ratio-ECTOSONE (TEVA-ECTOSONE) 0.1% regular and 0.05% mild lotions

Canada Type I Ongoing · initiated 2024-08-05

Product quality - Labelling. Do not use the affected products. Consult a health care professional if you have used these products and have health concerns.Retur…

EMPOWER CLINIC SERVICES LLC

US Class II Terminated · initiated 2024-08-02

Lack of Assurance of Sterility

Amneal Pharmaceuticals, LLC

US Class III Completed · initiated 2024-08-01

Presence of Foreign Tablets: Potential presence of Fludrocortisone Acetate Tablet USP 0.1 mg within the Methotrexate 2.5 mg 100-count Bottle.

Baxter Healthcare Corporation

US Class I Ongoing · initiated 2024-08-01

Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

Granules Pharmaceuticals Inc.

US Class II Terminated · initiated 2024-07-31

Presence of Foreign Tablets; 3 fused tablets of Metformin ER 500 mg were found in bottle of Gabapentin Tablets

Glenmark Pharmaceuticals Inc., USA

US Class II Ongoing · initiated 2024-07-31

Failed Dissolution Specifications: below specification results

VegiDay Vegan Organic ALL IN ONE

Canada Type II Ongoing · initiated 2024-07-29

Product safety. Verify if your product is affected. If yes, stop using the recalled product. Consult your healthcare practitioner if you have used the affected …

Hi Potency B Complex, RevitalX, Super Multi® IRON FREE

Canada Type II Ongoing · initiated 2024-07-29

Product safety. Verify if your product is affected. If yes, stop using the recalled product. Consult your healthcare practitioner if you have used the affected …

WN Pharmaceuticals Ltd products

Canada Type II Ongoing · initiated 2024-07-29

Product safety. Verify if your product is affected. If yes, stop using the recalled product. Consult your healthcare practitioner if you have used the affected …

Eugia US LLC

US Class II Ongoing · initiated 2024-07-26

Presence of Particulate Matter: Complaint received of a glass particle in the vial.

JAMP Pantoprazole Sodium

Canada Type II Ongoing · initiated 2024-07-25

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

B. Braun Medical Inc

US Class I Ongoing · initiated 2024-07-24

Presence of Particulate Matter

FDC Limited

US Class II Ongoing · initiated 2024-07-23

Defective container: unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.

Glenmark Pharmaceuticals Inc., USA

US Class II Ongoing · initiated 2024-07-22

CGMP Deviations

Granules Consumer Health Inc.

US Class III Terminated · initiated 2024-07-18

Label mix-up: Carton incorrectly labeled.